Literature DB >> 8537373

Binding affinities of tyrosine-phosphorylated peptides to the COOH-terminal SH2 and NH2-terminal phosphotyrosine binding domains of Shc.

M M Zhou1, J E Harlan, W S Wade, S Crosby, K S Ravichandran, S J Burakoff, S W Fesik.   

Abstract

The adaptor protein Shc has been implicated in Ras signaling via association with many tyrosine-phosphorylated receptors, including growth factor receptors, antigen receptors on T and B cells, and cytokine receptors. Shc could interact with the activated receptors through the carboxyl-terminal Src homology 2 (SH2) domain or the structurally unrelated amino-terminal phosphotyrosine binding (PTB) domain. Using NMR and surface plasmon resonance techniques, we have measured the binding affinities of the SH2 and the PTB domains of Shc to a series of phosphotyrosine-containing peptides derived from known Shc binding sites. Tyrosine-phosphorylated peptides derived from Trk (pY490), polyoma virus middle T-antigen (pY250), ErbB3 (pY1309), and epidermal growth factor receptor (pY1086, pY1148, and pY1114) that contain NPXpY sequences bind preferentially to the PTB domain of Shc with Kd values of 0.02-5.3 microM. The binding affinities of these peptides to the Shc SH2 domain were in the range of 220-1290 microM. In contrast, tyrosine-phosphorylated peptides from epidermal growth factor receptor (pY992, pY1173) and the zeta chain of the T-cell receptor bind preferentially to the SH2 domain (Kd = 50-130 microM) versus the PTB domain (Kd > 680 microM). From these studies, the relative contribution of the individual domains of Shc for binding to the phosphotyrosine-containing portions of these proteins was determined. In addition, our data indicate that the high affinity binding of the PTB domain to the NPXpY-containing peptides results from a very high association rate and a rapid dissociation rate, which is similar to previous results observed for the SH2-phosphopeptide complexes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8537373     DOI: 10.1074/jbc.270.52.31119

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Evidence for a requirement for both phospholipid and phosphotyrosine binding via the Shc phosphotyrosine-binding domain in vivo.

Authors:  K S Ravichandran; M M Zhou; J C Pratt; J E Harlan; S F Walk; S W Fesik; S J Burakoff
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  Redirecting tyrosine kinase signaling to an apoptotic caspase pathway through chimeric adaptor proteins.

Authors:  Perry L Howard; Marie C Chia; Suzanne Del Rizzo; Fei-Fei Liu; Tony Pawson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-17       Impact factor: 11.205

3.  Sequence-specific recognition of the internalization motif of the Alzheimer's amyloid precursor protein by the X11 PTB domain.

Authors:  Z Zhang; C H Lee; V Mandiyan; J P Borg; B Margolis; J Schlessinger; J Kuriyan
Journal:  EMBO J       Date:  1997-10-15       Impact factor: 11.598

4.  High-affinity binding of the Drosophila Numb phosphotyrosine-binding domain to peptides containing a Gly-Pro-(p)Tyr motif.

Authors:  S C Li; Z Songyang; S J Vincent; C Zwahlen; S Wiley; L Cantley; L E Kay; J Forman-Kay; T Pawson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

5.  The PTB domain of ShcA couples receptor activation to the cytoskeletal regulator IQGAP1.

Authors:  Matthew J Smith; W Rod Hardy; Guang-Yao Li; Marilyn Goudreault; Steven Hersch; Pavel Metalnikov; Andrei Starostine; Tony Pawson; Mitsuhiko Ikura
Journal:  EMBO J       Date:  2010-01-14       Impact factor: 11.598

6.  Physical modulation of intracellular signaling processes by locational regulation.

Authors:  J M Haugh; D A Lauffenburger
Journal:  Biophys J       Date:  1997-05       Impact factor: 4.033

7.  Molecular dynamics simulations reveal that Tyr-317 phosphorylation reduces Shc binding affinity for phosphotyrosyl residues of epidermal growth factor receptor.

Authors:  Atsushi Suenaga; Mariko Hatakeyama; Anatoly B Kiyatkin; Ravi Radhakrishnan; Makoto Taiji; Boris N Kholodenko
Journal:  Biophys J       Date:  2009-03-18       Impact factor: 4.033

8.  Essential roles for Dok2 and RasGAP in CD200 receptor-mediated regulation of human myeloid cells.

Authors:  Robin Mihrshahi; A Neil Barclay; Marion H Brown
Journal:  J Immunol       Date:  2009-09-28       Impact factor: 5.422

Review 9.  The ERBB3 receptor in cancer and cancer gene therapy.

Authors:  G Sithanandam; L M Anderson
Journal:  Cancer Gene Ther       Date:  2008-04-11       Impact factor: 5.987

10.  Identification of Shc Src homology 2 domain-binding peptoid-peptide hybrids.

Authors:  Won Jun Choi; Sung-Eun Kim; Andrew G Stephen; Iwona Weidlich; Alessio Giubellino; Fa Liu; Karen M Worthy; Lakshman Bindu; Matthew J Fivash; Marc C Nicklaus; Donald P Bottaro; Robert J Fisher; Terrence R Burke
Journal:  J Med Chem       Date:  2009-03-26       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.